Icarus Medical Raises $7.2 Million Series A to Expand Orthopedic Bracing Technology

Icarus Medical has closed a $7.2 million Series A funding round, announced in a press release. The company, based in Charlottesville, Virginia, originally targeted $5 million but exceeded that amount due to strong investor interest.

The financing will support expanded commercialization across the United States, continued product development, manufacturing growth, clinical validation of current devices, and team expansion. The company aims to strengthen its national presence in the orthopedic technology market.

Investors in the round include Riptide Ventures, OSF Ventures, CU Healthcare Innovation Fund, Highpoint Ventures, MedTech Connect, Neovate Capital Partners, and BLU Venture Investors. These partners will also provide strategic expertise in healthcare operations and commercialization.

Founded in Charlottesville, Icarus Medical develops orthopedic bracing technologies that combine biomechanics, additive manufacturing, and patient-focused design to help users maintain mobility while reducing pain and improving function.